Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara East

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of the American Heart Association|August 23, 2023
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MIXiaowen Wang, Karola S Jering, Maja Cikes, et al.
European Journal of Heart Failure|July 26, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MIFinnian R Mc Causland, Martina M McGrath, Brian L Claggett, et al.
Journal of the American Society of Hypertension : JASH|September 13, 2015
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trialJohn M Flack, Deepak L Bhatt, David E Kandzari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 3, 2021
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKFDavid E Kandzari, Raymond R Townsend, George Bakris, et al.
Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 19, 2022
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trialMichael A Weber, Roland E Schmieder, David E Kandzari, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|April 3, 2020
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Kazuomi Kario, David E Kandzari, et al.
The New England Journal of Medicine|November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial InfarctionMarc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
Lancet (London, England)|September 2, 2017
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialRaymond R Townsend, Felix Mahfoud, David E Kandzari, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the American Heart Association|August 23, 2023
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MIXiaowen Wang, Karola S Jering, Maja Cikes, et al.
European Journal of Heart Failure|July 26, 2024
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MIFinnian R Mc Causland, Martina M McGrath, Brian L Claggett, et al.
Journal of the American Society of Hypertension : JASH|September 13, 2015
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trialJohn M Flack, Deepak L Bhatt, David E Kandzari, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 3, 2021
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKFDavid E Kandzari, Raymond R Townsend, George Bakris, et al.
Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 19, 2022
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trialMichael A Weber, Roland E Schmieder, David E Kandzari, et al.
Journal of the American College of Cardiology|November 1, 2023
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E Kandzari, Raymond R Townsend, Kazuomi Kario, et al.
Lancet (London, England)|April 3, 2020
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Kazuomi Kario, David E Kandzari, et al.
The New England Journal of Medicine|November 10, 2021
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial InfarctionMarc A Pfeffer, Brian Claggett, Eldrin F Lewis, et al.
Lancet (London, England)|September 2, 2017
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialRaymond R Townsend, Felix Mahfoud, David E Kandzari, et al.
Pageof 3